公开(公告)号：US20210147363A1

公开(公告)日：2021-05-20

申请号：US17069386

申请日：2020-10-13

Applicant: Xenon Pharmaceuticals Inc.

Inventor： Paul Robert BICHLER ,  Jean-Jacques Alexandre CADIEUX ,  Matthew David TANDY ,  Gregory N. BEATCH

IPC: C07D217/04

Abstract: The present disclosure provides solid state forms of a selective potassium channel modulator and pharmaceutical compositions comprising the solid state crystalline forms and pharmaceutically acceptable excipients, and methods for preparing and using the solid state forms and the pharmaceutical compositions thereof.

公开(公告)号：US20220064120A1

公开(公告)日：2022-03-03

申请号：US17368766

申请日：2021-07-06

Applicant: Xenon Pharmaceuticals Inc.

Inventor： Paul Robert BICHLER ,  Jean-Jacques Alexandre CADIEUX ,  Matthew David TANDY ,  Gregory N. BEATCH

IPC: C07D217/04

Abstract: The present disclosure provides solid state forms of a selective potassium channel modulator and pharmaceutical compositions comprising the solid state crystalline forms and pharmaceutically acceptable excipients, and methods for preparing and using the solid state forms and the pharmaceutical compositions thereof.